AstraZeneca to Open New Site in Kendall Square
- Posted by ISPE Boston
- On May 13, 2022
AstraZeneca plans to open a new site at the heart of the Cambridge life sciences and innovation hub. The new site will be a strategic R&D center for AstraZeneca, as well as corporate headquarters for Alexion, which was acquired by AstraZeneca in July 2021. The site will consolidate approximately 1,500 R&D, commercial and corporate professionals […]
Read More